163 related articles for article (PubMed ID: 9217996)
1. Complementation group assignments in Fanconi anemia fibroblast cell lines from North America.
Jakobs PM; Fiddler-Odell E; Reifsteck C; Olson S; Moses RE; Grompe M
Somat Cell Mol Genet; 1997 Jan; 23(1):1-7. PubMed ID: 9217996
[TBL] [Abstract][Full Text] [Related]
2. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
[TBL] [Abstract][Full Text] [Related]
3. Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.
Yamashita T; Wu N; Kupfer G; Corless C; Joenje H; Grompe M; D'Andrea AD
Blood; 1996 May; 87(10):4424-32. PubMed ID: 8639804
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
Tomkins DJ; Care M; Carreau M; Buchwald M
Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
[TBL] [Abstract][Full Text] [Related]
5. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
[TBL] [Abstract][Full Text] [Related]
6. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
[TBL] [Abstract][Full Text] [Related]
7. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
Yamashita T; Nakahata T
Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
9. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups.
Li Y; Youssoufian H
J Clin Invest; 1997 Dec; 100(11):2873-80. PubMed ID: 9389754
[TBL] [Abstract][Full Text] [Related]
10. Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines.
Kruyt FA; Dijkmans LM; van den Berg TK; Joenje H
Blood; 1996 Feb; 87(3):938-48. PubMed ID: 8562965
[TBL] [Abstract][Full Text] [Related]
11. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
[TBL] [Abstract][Full Text] [Related]
12. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
13. Sequence variations in the Fanconi anaemia gene, FAC: pathogenicity of 1806insA and R548X and recognition of D195V as a polymorphic variant.
Lo ten Foe JR; Barel MT; Thuss P; Digweed M; Arwert F; Joenje H
Hum Genet; 1996 Nov; 98(5):522-3. PubMed ID: 8882868
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathogenesis of fanconi anemia.
Taniguchi T; Dandrea AD
Int J Hematol; 2002 Feb; 75(2):123-8. PubMed ID: 11939257
[TBL] [Abstract][Full Text] [Related]
16. Novel mutations and polymorphisms in the Fanconi anemia group C gene.
Gibson RA; Morgan NV; Goldstein LH; Pearson IC; Kesterton IP; Foot NJ; Jansen S; Havenga C; Pearson T; de Ravel TJ; Cohn RJ; Marques IM; Dokal I; Roberts I; Marsh J; Ball S; Milner RD; Llerena JC; Samochatova E; Mohan SP; Vasudevan P; Birjandi F; Hajianpour A; Murer-Orlando M; Mathew CG
Hum Mutat; 1996; 8(2):140-8. PubMed ID: 8844212
[TBL] [Abstract][Full Text] [Related]
17. Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure.
Jakobs PM; Sahaayaruban P; Saito H; Reifsteck C; Olson S; Joenje H; Moses RE; Grompe M
Somat Cell Mol Genet; 1996 Mar; 22(2):151-7. PubMed ID: 8782494
[TBL] [Abstract][Full Text] [Related]
18. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
19. Retroviral gene transfer for the assignment of Fanconi anemia (FA) patients to a FA complementation group.
Fu KL; Thuss PC; Fujino T; Digweed M; Liu JM; Walsh CE
Hum Genet; 1998 Feb; 102(2):166-9. PubMed ID: 9521584
[TBL] [Abstract][Full Text] [Related]
20. Positional cloning of the Fanconi anaemia group A gene.
Fanconi anaemia/Breast cancer consortium
Nat Genet; 1996 Nov; 14(3):324-8. PubMed ID: 8896564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
